ALBT: Avalon GloboCare Corp. Stock

by  •  • Comments Off on ALBT: Avalon GloboCare Corp. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 2.68
Enterprise Value ($M) 30.77
Book Value ($M) 7.37
Book Value / Share 0.66
Price / Book 0.36
NCAV ($M) -12.36
NCAV / Share -1.11
Price / NCAV -0.22

Profitability (mra)
Return on Invested Capital (ROIC) -1.05
Return on Assets (ROA) -0.54
Return on Equity (ROE) -0.84

Liquidity (mrq)
Quick Ratio 0.13
Current Ratio 0.13

Balance Sheet (mrq) ($M)
Current Assets 0.85
Assets 20.58
Liabilities 13.21
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue -7.33
Operating Income -15.77
Net Income -16.71
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -6.50
Cash from Investing -0.02
Cash from Financing 4.83

(click for more detail)
Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-04-15 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTI
2023-11-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-08-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 ☐ TRANSITION REPORT PURSUANT TO S
2023-05-22 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-05-03 3,168 30,955 10.23
2024-05-02 640 1,757 36.43
2024-05-01 567 1,015 55.86
2024-04-30 428 1,342 31.89

(click for more detail)

Similar Companies
AIMD – Ainos, Inc. AKAN – Akanda Corp.
AKBA – Akebia Therapeutics, Inc. ALDX – Aldeyra Therapeutics, Inc.
ALGS – Aligos Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io